Personal Genome Diagnostics (PGDx)
Megan Bailey has more than 18 years of leadership experience in the healthcare industry. As Chief Executive Officer of Personal Genome Diagnostics (PGDx), she leverages her extensive knowledge of clinical diagnostics, business development and commercialization to lead a team focused on providing precision cancer care solutions that allow all patients to have access to best-in-class genomic testing. Prior to her role as CEO, she served as Chief Commercial Officer, leading the Company’s marketing, sales, and customer support teams, and before that, as Vice President of Marketing.
She began her career in diagnostics with Ventana Medical Systems, a company with a patient-focused mission to improve cancer diagnostics globally. Following Roche Diagnostics’ acquisition of Ventana in 2008, Megan spent the next 10 years rapidly progressing through commercial leadership roles of increasing responsibility. In her last role at Roche, she served as Senior Director of Commercial Operations, responsible for a $200M+ portfolio across four Divisions, addressing multiple disease states and market segments.